Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 23.21
(-1.9%)
CNY 23.21
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.28 Billion | 3.56 Billion | 1.86 Billion | 1.56 Billion | 268.38 Million | 170.8 Million |
| Cost of Revenue | 514.88 Million | 1.11 Billion | 350.84 Million | 133.63 Million | 42.08 Million | 29.84 Million |
| Gross Profit | 768.68 Million | 2.45 Billion | 1.51 Billion | 1.43 Billion | 226.29 Million | 140.96 Million |
| Operating Expenses | 1.01 Billion | 1.22 Billion | 721.36 Million | 408.11 Million | 198.93 Million | 137.51 Million |
| Selling, General and Administrative Expenses | 701.59 Million | 627.53 Million | 405.22 Million | 241.35 Million | 114.65 Million | 76.95 Million |
| Research and Development Expenses | 338.61 Million | 396.1 Million | 230.32 Million | 125.53 Million | 62.29 Million | 53 Million |
| Other Expenses | 146.43 Million | 197.86 Million | 85.82 Million | 41.23 Million | 21.97 Million | -110.59 Thousand |
| Cost and Expenses | 1.38 Billion | 2.33 Billion | 1.07 Billion | 541.75 Million | 241.01 Million | 167.36 Million |
| Operating Income | -100.18 Million | 1.19 Billion | 771.13 Million | 973.01 Million | 24.31 Million | 526.12 Thousand |
| Interest Expense | 36.2 Million | 12.47 Million | 3.86 Million | 1.02 Million | 402.17 Thousand | 901.66 Thousand |
| Income Tax Expense | -42.85 Million | 15.88 Million | 86.15 Million | 137.53 Million | -1.42 Million | -623.18 Thousand |
| Earnings before Tax | -115.71 Million | 609.38 Million | 764.44 Million | 959.25 Million | 24.36 Million | 415.53 Thousand |
| Net Income | -70.95 Million | 594.24 Million | 678.28 Million | 821.72 Million | 25.79 Million | 1.03 Million |
| Earnings Per Share Basic | -0.18 | 1.49 | 1.70 | 2.05 | 0.06 | 0.00 |
| Earnings Per Share Diluted | -0.18 | 1.49 | 1.70 | 2.05 | 0.06 | 0.00 |
| Weighted Average Shares Outstanding | 394.2 Million | 400.01 Million | 400.01 Million | 400.01 Million | 400.01 Million | 355.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 394.2 Million | 400.01 Million | 400.01 Million | 400.01 Million | 400.01 Million | 355.72 Million |
| Gross Margin | 0.60 | 0.69 | 0.81 | 0.91 | 0.84 | 0.83 |
| EBIT Margin | 0.12 | 0.37 | 0.47 | 0.66 | 0.13 | 0.05 |
| Profit Margin | -0.06 | 0.17 | 0.36 | 0.53 | 0.10 | 0.01 |
| EBITDA | 156.12 Million | 841.8 Million | 853.11 Million | 983.88 Million | 38.37 Million | 8.76 Million |
| Earnings Before Tax Margin | -0.08 | 0.34 | 0.41 | 0.62 | 0.09 | 0.00 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 336.63 Million | 343.61 Million | 299.5 Million | 417.43 Million | 1.28 Billion | 298.25 Million |
| Cost of Revenue | 101.07 Million | 126.71 Million | 87.25 Million | 142.41 Million | 461.39 Million | 94.44 Million |
| Gross Profit | 235.55 Million | 216.89 Million | 212.24 Million | 275.02 Million | 822.17 Million | 203.81 Million |
| Operating Expenses | 243.98 Million | 226.62 Million | 238 Million | 352.32 Million | 1.1 Billion | 210.18 Million |
| Selling, General and Administrative Expenses | 389.77 Million | 162.41 Million | 158.54 Million | 210.63 Million | - | 243.36 Million |
| Research and Development Expenses | 72.02 Million | 61.12 Million | 70.76 Million | 81.76 Million | - | 74.48 Million |
| Other Expenses | -217.8 Million | -3.09 Million | -8.7 Million | -59.91 Million | -140.91 Million | -10.82 Million |
| Cost and Expenses | 345.06 Million | 353.33 Million | 325.26 Million | 494.73 Million | 1.56 Billion | 304.62 Million |
| Operating Income | -8.14 Million | -9.72 Million | -25.75 Million | -77.29 Million | -280.2 Million | 9.53 Million |
| Interest Expense | 7 Million | 7.53 Million | 8.96 Million | 7.54 Million | 35.06 Million | 12.26 Million |
| Income Tax Expense | -9.69 Million | -8.29 Million | -7.24 Million | -12.32 Million | -42.85 Million | -5.56 Million |
| Earnings before Tax | -7.98 Million | 2.13 Million | -2.36 Million | -7.46 Million | -115.71 Million | -1.29 Million |
| Net Income | 1.99 Million | 10.94 Million | 5.21 Million | 5.43 Million | -70.95 Million | 4.7 Million |
| Earnings Per Share Basic | 0.01 | 0.03 | 0.01 | 0.01 | - | 0.01 |
| Earnings Per Share Diluted | 0.01 | 0.03 | 0.01 | 0.01 | - | 0.01 |
| Weighted Average Shares Outstanding | 395.09 Million | 395.92 Million | 396.99 Million | 399.39 Million | 399.39 Million | 399.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 395.09 Million | 395.92 Million | 396.99 Million | 405.35 Million | 399.39 Million | 399.81 Million |
| Gross Margin | 0.70 | 0.63 | 0.71 | 0.66 | 0.64 | 0.68 |
| EBIT Margin | -0.00 | 0.13 | 0.00 | -0.05 | - | 0.02 |
| Profit Margin | 0.01 | 0.03 | 0.02 | 0.01 | -0.06 | 0.02 |
| EBITDA | -986.7 Thousand | 43.56 Million | 14.48 Thousand | -21.5 Million | - | 5.57 Million |
| Earnings Before Tax Margin | -0.02 | -0.03 | -0.09 | -0.19 | -0.22 | 0.03 |
CHKEL
7939
EMX
2340
EPAC
3164